The Latest Cardiac and Vascular News
WAKEFIELD, Mass., June 13, 2022 /PRNewswire/ — Ablative Solutions, Inc., a company pioneering new approaches to the treatment of hypertension, today announced the completion of the fourth tranche of its Series D financing round, resulting in $91.4 million in aggregate proceeds to the Company from the Series D financing round. Gilde Healthcare, BioStar Capital, Invus […]
CAMBRIDGE, Mass., June 13, 2022 (GLOBE NEWSWIRE) — Verve Therapeutics, a biotechnology company pioneering a new approach to the care of cardiovascular disease with single-course gene editing medicines, today announced that Alexander G. “Bo” Cumbo, chief executive officer and president of AavantiBio, Inc., has joined the company’s board of directors. “Bo […]
Existing investor syndicate supports atrial shunting as effective therapy for heart failure patients TEWKSBURY, Mass., June 9, 2022 /PRNewswire/ — Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure (HF), today announced the closing of a $54 million equity financing from its existing investor syndicate. Funds will be utilized to […]
Nonprofit dedicated to advancing treatment and education for congenital heart defects will award a $5,000 Grant to a deserving hospital-based advanced cardiology fellow Hollis, NH (December 13, 2021) – Heartfelt Dreams Foundation, a nonprofit organization dedicated to enhancing the treatment experience for congenital heart defect (CHD) patients and their families […]
MLS-101 is a Highly Selective Aldosterone Synthase Inhibitor Designed to Address Abnormally Elevated Aldosterone, an Underlying Cause of Hypertension Prevalent in a Significant Portion of Patients Derek DiRocco of RA Capital Management and Olivier Litzka, PhD of Andera Partners Join Mineralys Board of Directors PHILADELPHIA, June 8, 2022 /PRNewswire/ — Mineralys Therapeutics, Inc., a private, […]
WASHINGTON–(BUSINESS WIRE)–CorVista Health, Inc., a digital health company dedicated to improving cardiovascular disease diagnosis, announces the expansion of their Medical Advisory Board with the appointment of Drs. Vallerie V. McLaughlin and Mark G. Rabbat. The expansion of the Medical Advisory Board reflects the company’s focus on pulmonary hypertension, coronary artery disease […]
Estimated May Revenue Increase of 96% Year Over Year Sales Funnel Increases 5% and System Trials Increases 2% Month Over Month SUWANEE, GA, June 07, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — On June 7, 2022, SANUWAVE Health, Inc. (OTC: PINK: SNWV), a leading provider of next-generation wound care products, provided an […]
— Company Expects to Achieve Approximately $100 Million in Cost Savings Over the Next 12 Months* While Continuing to Invest in European Launches and Global Expansion — — Reduces U.S. Commercial Organization by Ninety Percent of Pre-Pandemic / Pre-Generic Competition Levels — — Creates Core Focused U.S. Commercial Team to […]
— Experienced Executive Brings More Than Twenty Years of Global Financial Leadership to Amarin — — Michael W. Kalb to Depart Amarin to Pursue Other Interests — DUBLIN, Ireland and BRIDGEWATER, N.J., June 06, 2022 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN) today announced the appointment of Tom Reilly as […]
Boston, Massachusetts, June 1, 2022 Broadview Ventures, a mission-driven investment firm dedicated to accelerating the development of promising technology for the diagnosis and treatment of cardiovascular disease and stroke, today announces the promotion of Maria Berkman to Managing Director of Longview Ventures. Longview Ventures is an independent investment vehicle that makes […]
